Neuraptive Therapeutics Inc.
Neuraptive is a biotechnology company developing novel therapeutics and medical products to address unmet needs in peripheral nerve injuries. Their mission is to improve outcomes for physicians and patients impacted by nerve injuries through innovative science and technology, including nerve fusion systems, drug delivery devices, and microsurgical instruments.
Industries
Nr. of Employees
small (1-50)
Neuraptive Therapeutics Inc.
851 Duportail Road, Suite 200, Chesterbrook, PA 19087
Patents
Device and method of creating a fluid containment field for administering therapeutics to a nerve
US-12383273-B2
View DetailsDevice and method of creating a fluid containment field for administering therapeutics to a nerve
US-11633188-B2
View Details
Device and method of creating a fluid containment field for administering therapeutics to a nerve
US-12383273-B2
View DetailsDevice and method of creating a fluid containment field for administering therapeutics to a nerve
US-11633188-B2
View DetailsProducts
Single-use intraoperative nerve repair kit (fusion reagents, topical delivery device, instruments)
A single-use surgical kit intended for use with standard neurorrhaphy that combines PEG-based fusion reagents, a topical nerve drug-delivery device and nerve-specific microsurgical instruments to restore electrical signaling across a severed peripheral nerve intraoperatively.
Single-use intraoperative nerve repair kit (fusion reagents, topical delivery device, instruments)
A single-use surgical kit intended for use with standard neurorrhaphy that combines PEG-based fusion reagents, a topical nerve drug-delivery device and nerve-specific microsurgical instruments to restore electrical signaling across a severed peripheral nerve intraoperatively.
Services
Intake and review of external collaboration proposals, technology disclosures and licensing opportunities for alignment with peripheral nerve repair development programs.
Case-by-case evaluation and management of requests for investigational product outside clinical trials, including physician intake, documentation review and compliance checks.
Intake and review of external collaboration proposals, technology disclosures and licensing opportunities for alignment with peripheral nerve repair development programs.
Case-by-case evaluation and management of requests for investigational product outside clinical trials, including physician intake, documentation review and compliance checks.
Expertise Areas
- Peripheral nerve repair therapeutics
- Surgical device and kit development
- Clinical trial management for surgical adjuncts
- Regulatory strategy and FDA interactions (IND, Fast Track, Breakthrough, Orphan)
Key Technologies
- Polyethylene glycol (PEG)-based axonal fusion
- Topical localized nerve drug-delivery devices
- Single-use sterile surgical kits
- Nerve-specific microsurgical instruments
News & Updates
Presentation of interim results for NTX-001 at the 2024 American Society for Surgery of the Hand Annual Meeting.
The company announced FDA Breakthrough Therapy Designation for NTX-001 for peripheral nerve injury treatment.
Reinforcing proof of concept with positive data for NTX-001.
FDA cleared the Investigational New Drug application for NTX-001 for nerve injuries.
Presentation of interim results for NTX-001 at the 2024 American Society for Surgery of the Hand Annual Meeting.
The company announced FDA Breakthrough Therapy Designation for NTX-001 for peripheral nerve injury treatment.
Reinforcing proof of concept with positive data for NTX-001.
FDA cleared the Investigational New Drug application for NTX-001 for nerve injuries.